(Q83821639)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21479767%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

title

Novel multidrug therapy for children with cyclosporine-resistant or -intolerant nephrotic syndrome (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21479767%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

main subject

multiple drug resistance

1 reference

1 reference

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21479767%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

author name string

Tomomi Aizawa-Yashiro

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21479767%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Kazushi Tsuruga

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21479767%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Shojiro Watanabe

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21479767%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Eishin Oki

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21479767%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Etsuro Ito

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21479767%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

publication date

9 April 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21479767%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21479767%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21479767%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21479767%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

page(s)

1255-1261

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21479767%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00467-011-1876-z

28 January 2020

exact match

0 references

cites work

The primary nephrotic syndrome in children. Identification of patients with minimal change nephrotic syndrome from initial response to prednisone. A report of the International Study of Kidney Disease in Children

1 reference

12 December 2020

A multicenter trial of mizoribine compared with placebo in children with frequently relapsing nephrotic syndrome

1 reference

12 December 2020

Management of steroid-resistant focal segmental glomerulosclerosis in children using tacrolimus

1 reference

12 December 2020

The immunosuppressive drug mizoribine directly prevents podocyte injury in puromycin aminonucleoside nephrosis

1 reference

12 December 2020

Effect of conversion from cyclosporine A to mizoribine on transplant arteriosclerosis in rat aortic allograft models

1 reference

12 December 2020

Tacrolimus: a new therapy for steroid-resistant nephrotic syndrome in children

1 reference

12 December 2020

Cyclosporine and steroid therapy in children with steroid-resistant nephrotic syndrome

1 reference

12 December 2020

Management of young patients with lupus nephritis using tacrolimus administered as a single daily dose.

1 reference

12 December 2020

Treatment of idiopathic membranous nephropathy with the combination of steroids, tacrolimus and mycophenolate mofetil: results of a pilot study

1 reference

12 December 2020

Combination therapy of mycophenolate mofetil and tacrolimus in lupus nephritis

1 reference

12 December 2020

Mizoribine attenuates renal injury and macrophage infiltration in patients with severe lupus nephritis.

1 reference

12 December 2020

Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience

1 reference

12 December 2020

Mycophenolate mofetil in the treatment of focal segmental glomerulosclerosis.

1 reference

12 December 2020

Nephrotic syndrome and mizoribine in children.

1 reference

12 December 2020

Does kL/PCr estimate GFR, or does GFR determine k?

1 reference

12 December 2020

Benefits of once-daily administration of cyclosporine a for children with steroid-dependent, relapsing nephrotic syndrome.

1 reference

12 December 2020

Tacrolimus for the treatment of focal segmental glomerulosclerosis resistant to cyclosporine A

1 reference

12 December 2020

Follow-up study of children with nephrotic syndrome treated with a long-term moderate dose of cyclosporine.

1 reference

12 December 2020

Protective effects of Mizoribine on Cyclosporine A nephropathy in rats

1 reference

12 December 2020

Long-term outcome of children with steroid-resistant nephrotic syndrome treated with tacrolimus

1 reference

12 December 2020

Mycophenolate mofetil therapy for children with intractable nephrotic syndrome

1 reference

12 December 2020

Two-year cyclosporin treatment in children with steroid-dependent nephrotic syndrome

1 reference

12 December 2020

Experience with tacrolimus in children with steroid-resistant nephrotic syndrome

1 reference

12 December 2020

Benefits of cyclosporine absorption profiling in nephrotic syndrome: preprandial once-daily administration of cyclosporine microemulsion improves slow absorption and can standardize the absorption profile

1 reference

12 December 2020

A novel multidrug therapy for difficult cyclosporine-resistant focal segmental glomerulosclerosis.

1 reference

12 December 2020